FAQ

Hepatitis B Virus Core Antibody Measurement

Known as: HBCAB, Hepatitis B Virus Core Antibody 
The determination of the amount of Hepatitis B virus core antibody present in a sample.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2018
02419932018

Related topics

Related topics

4 relations
Antibody to hepatitis B core antigenCDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Related mentions per year

Related mentions per year

1971-2018
197019801990200020102020
Hepatitis B Virus Core Antibody Measurement
Antibody to hepatitis B core antigen
Clinical Data Interchange Standards Consortium Terminology
CDISC SDTM Laboratory Test Terminology by Code
CDISC SDTM Laboratory Test Terminology by Name

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.
BACKGROUND & AIMS Previous studies predicted the prognosis of hepatocellular carcinoma (HCC) mainly based on tumour-related… (More)
Is this relevant?
2016
2016
Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.
PURPOSE The purpose of this study was to characterize roles of serum hepatitis B virus marker quantitation in differentiation of… (More)
Is this relevant?
2015
2015
Performance evaluation of four dominant anti-hepatitis B core antigen (HBcAb) kits in Japan for preventing de novo hepatitis B virus (HBV) infection.
BACKGROUND The determination of antibody to hepatitis B core antigen (HBcAb) has become an important means of evaluating the risk… (More)
Is this relevant?
2014
2014
Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis
BACKGROUND HBV and HCV reactivation have been widely reported in patients undergoing immunosuppressive therapy (IT); however, few… (More)
  • table 1
  • table 2
Is this relevant?
2013
2013
Intra-familial Transmission of Hepatitis B virus Infection in Zahedan
BACKGROUND The household transmission of hepatitis B virus (HBV) is a major health problem. The prevalence rate of this infection… (More)
  • table 2
Is this relevant?
2012
2012
Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania.
No recent data are available on hepatitis B virus (HBV) and hepatitis Delta virus (HDV) prevalence in Mauritania. One thousand… (More)
Is this relevant?
2008
2008
Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin’s lymphoma in Hokkaido
Dear Editor, Despite the low immunosuppressive effects of rituximab, severe viral infections due to varicella zoster virus… (More)
  • table 1
  • table 2
Is this relevant?
2007
2007
Clinical characteristics of NonBNonC- HCC: Comparison with HBV and HCV related HCC.
OBJECTIVE To clarify the frequency and trends of both HBsAg and HCVAb negative hepatocellular carcinoma (NonBNonC-HCC) in all HCC… (More)
Is this relevant?
2006
2006
Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
UNLABELLED Hepatocellular carcinoma (HCC) is one of the common malignancies worldwide including Asian countries. Chronic viral… (More)
Is this relevant?
2001
2001
Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health.
PURPOSE To evaluate hepatitis B (HBV) vaccine response rates in HIV infected and high-risk HIV uninfected youth and examine… (More)
Is this relevant?